               SEQUENCE LISTING

<110> CISBIO BIOASSAYS

<120> Anticorps anti-protéine Galphai

<130> 1H305110 0037 

<150> FR2000923
<151> 2020-01-30

<160> 15

<170> BiSSAP 1.3.6

<210> 1
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> VH-CDR1

<400> 1
Gly Phe Asn Ile Lys Asp Tyr Tyr 
1               5               

<210> 2
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> VH-CDR2

<400> 2
Ile Asp Pro Glu Asn Gly Asn Thr 
1               5               

<210> 3
<211> 14
<212> PRT
<213> Artificial Sequence


<220> 
<223> VH-CDR3

<400> 3
Thr Arg Gly Gly Gly Tyr Tyr Ser Asp Trp Tyr Phe Asp Val 
1               5                   10                  

<210> 4
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> VL-CDR1

<400> 4
Ser Ser Val Ser Tyr 
1               5   

<210> 5
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> VL-CDR3

<400> 5
Gln Gln Trp Ser Ser Asn Pro Pro Ile Thr 
1               5                   10  

<210> 6
<211> 25
<212> PRT
<213> Artificial Sequence


<220> 
<223> VH-FR1

<400> 6
Glu Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Ala 
1               5                   10                  15      
Leu Val Lys Leu Ser Cys Lys Ala Ser 
            20                  25  

<210> 7
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> VH-FR2

<400> 7
Met His Trp Val Lys Gln Arg Pro Glu Gln Gly Leu Glu Trp Ile Gly 
1               5                   10                  15      
Trp 
    

<210> 8
<211> 38
<212> PRT
<213> Artificial Sequence


<220> 
<223> VH-FR3

<400> 8
Ile Tyr Asp Pro Lys Phe Gln Gly Lys Ala Ser Ile Thr Ala Asp Thr 
1               5                   10                  15      
Ser Ser Asn Thr Ala Tyr Leu Gln Leu Ser Ser Leu Thr Ser Glu Asp 
            20                  25                  30          
Thr Ala Val Tyr Tyr Cys 
        35              

<210> 9
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> VH-FR4

<400> 9
Trp Gly Ala Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      

<210> 10
<211> 26
<212> PRT
<213> Artificial Sequence


<220> 
<223> VL-FR1

<400> 10
Gln Ile Val Leu Thr Gln Ser Pro Ala Ile Met Ser Ala Ser Pro Gly 
1               5                   10                  15      
Glu Lys Val Thr Met Thr Cys Ser Ala Ser 
            20                  25      

<210> 11
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> VL-FR2

<400> 11
Met His Trp Tyr Gln Gln Lys Ser Gly Thr Ser Pro Lys Arg Trp Ile 
1               5                   10                  15      
Tyr 
    

<210> 12
<211> 36
<212> PRT
<213> Artificial Sequence


<220> 
<223> VL-FR3

<400> 12
Lys Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser Gly Ser Gly 
1               5                   10                  15      
Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Ala Glu Asp Ala Ala 
            20                  25                  30          
Thr Tyr Tyr Cys 
        35      

<210> 13
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> VL-FR4

<400> 13
Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys 
1               5                   10  

<210> 14
<211> 121
<212> PRT
<213> Artificial Sequence


<220> 
<223> Domaine variable de la chaîne lourde (VH)

<400> 14
Glu Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Ala 
1               5                   10                  15      
Leu Val Lys Leu Ser Cys Lys Ala Ser Gly Phe Asn Ile Lys Asp Tyr 
            20                  25                  30          
Tyr Met His Trp Val Lys Gln Arg Pro Glu Gln Gly Leu Glu Trp Ile 
        35                  40                  45              
Gly Trp Ile Asp Pro Glu Asn Gly Asn Thr Ile Tyr Asp Pro Lys Phe 
    50                  55                  60                  
Gln Gly Lys Ala Ser Ile Thr Ala Asp Thr Ser Ser Asn Thr Ala Tyr 
65                  70                  75                  80  
Leu Gln Leu Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      
Thr Arg Gly Gly Gly Tyr Tyr Ser Asp Trp Tyr Phe Asp Val Trp Gly 
            100                 105                 110         
Ala Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     

<210> 15
<211> 107
<212> PRT
<213> Artificial Sequence


<220> 
<223> Domaine variable de la chaîne légère (VL)

<400> 15
Gln Ile Val Leu Thr Gln Ser Pro Ala Ile Met Ser Ala Ser Pro Gly 
1               5                   10                  15      
Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met 
            20                  25                  30          
His Trp Tyr Gln Gln Lys Ser Gly Thr Ser Pro Lys Arg Trp Ile Tyr 
        35                  40                  45              
Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser 
    50                  55                  60                  
Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Ala Glu 
65                  70                  75                  80  
Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Pro Ile 
                85                  90                  95      
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys 
            100                 105         

